Skip to main content

Table 6 Chemotherapy agents used within the study population

From: Outcomes of implant-based oral rehabilitation in head and neck oncology patients—a retrospective evaluation of a large, single regional service cohort

Chemotherapy agents No. of patients
Carboplatin 13
Cisplatin 10
Cetuximab 2
MAP chemo (methotrexate, doxorubicin, cisplatin) 2
R-CHOP (rituximab, cyclophosphoamide, doxorubicin, vincristine, prednisolone) 1
TPF (docetaxel, cisplatin, 5-fluorouracil) 1
Carboplatin and paclitaxel 1
Total 30
  1. The drugs and regimes of chemotherapy agents used within the study population in the management of their head and neck cancer